1986
DOI: 10.1016/0014-2999(86)90276-1
|View full text |Cite
|
Sign up to set email alerts
|

High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
34
0

Year Published

1990
1990
2010
2010

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 107 publications
(34 citation statements)
references
References 23 publications
0
34
0
Order By: Relevance
“…Receptors containing the a1 subunit exhibit BZ 1 receptor pharmacology, with a high affinity for classical BZ agonists, such as diazepam and alprazolam, and also for the atypical BZ agonists, CL218872 and zolpidem. Transfection studies of recombinant GABA A receptors comprised of a1, b, g1, or g2 subunits exhibit BZ 1 receptor pharmacology, with highaffinity binding for zolpidem (Barnard et al, 1988;Mehta and Ticku, 1999), which binds BZ 1 receptors with an affinity (k d B7 nM) that is at least 20 times greater than for BZ 2 receptors (Arbilla et al, 1986). Receptors composed of the a2, a3, or a5 subunits show BZ 2 receptor profiles, with high affinity for classical BZ agonists, but greatly reduced affinity for zolpidem.…”
Section: Discussionmentioning
confidence: 99%
“…Receptors containing the a1 subunit exhibit BZ 1 receptor pharmacology, with a high affinity for classical BZ agonists, such as diazepam and alprazolam, and also for the atypical BZ agonists, CL218872 and zolpidem. Transfection studies of recombinant GABA A receptors comprised of a1, b, g1, or g2 subunits exhibit BZ 1 receptor pharmacology, with highaffinity binding for zolpidem (Barnard et al, 1988;Mehta and Ticku, 1999), which binds BZ 1 receptors with an affinity (k d B7 nM) that is at least 20 times greater than for BZ 2 receptors (Arbilla et al, 1986). Receptors composed of the a2, a3, or a5 subunits show BZ 2 receptor profiles, with high affinity for classical BZ agonists, but greatly reduced affinity for zolpidem.…”
Section: Discussionmentioning
confidence: 99%
“…Even if its effect seemed to be weaker than that of 5 mg/kg DZ, we cannot directly compare the efficacy of the two drugs to induce a long-lasting neurobiological change when using only one dose. Although the affinities of ZOL and DZ for the a1 subunit-containing receptors might be similar or differ slightly (about twofold) in recombinant a1b2/3g2 GABA A receptors (Wieland and Lüddens, 1994;Atack et al, 1999) and in a1 subunit-enriched regions of the rat brain (Arbilla et al, 1986;Benavides et al, 1988), the most important difference might be in the time course of action. ZOL is a short-acting hypnotic, with in vivo occupancy of the GABA A receptor BZ sites lasting only about 15-30 min after i.p.…”
Section: Discussionmentioning
confidence: 99%
“…Based on their affinity for different drugs, two different benzodiazepine binding sites have been identified in the central nervous system. Type I (benzodiazepine receptor 1, 1 ) displays high affinity for CL 218,872 (2), ␤-carboline derivates (3), and the imidazopyridine zolpidem (4,5). Type II (benzodiazepine receptor 2, 2 ) displays low affinity for these compounds.…”
mentioning
confidence: 99%